Jeff Liter, CEO of Luminary Therapeutics, discusses the importance of demonstrating clinical evidence at the JP Morgan Healthcare Conference.
Jeff Liter
Advertisement
Articles by Jeff Liter
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Pharma Companies Raise List Prices, Including 16 That Had Agreements to Lower Prices with Trump Administration: Report
2
JP Morgan 2026: Novavax Shifting Towards Partnership-Driven Strategy
3
What is Daiichi Sankyo’s Strategy for Preparing for the JP Morgan Healthcare Conference?
4
Why Was There Such an Emphasis on Data Collection at this Year's Conference?
5